ProfileGDS5678 / 1455888_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 29% 29% 29% 28% 28% 29% 37% 29% 28% 29% 29% 29% 29% 29% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.7011929
GSM967853U87-EV human glioblastoma xenograft - Control 22.668629
GSM967854U87-EV human glioblastoma xenograft - Control 32.6657129
GSM967855U87-EV human glioblastoma xenograft - Control 42.5963228
GSM967856U87-EV human glioblastoma xenograft - Control 52.5940628
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.7382929
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.8998837
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.6372829
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.6229428
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.6475229
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.6481929
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.6323329
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.6557629
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.6540829